About the Journal
OPEN ACCESS STATEMENT
European Journal of Management Issues (EJMI) publishes fully open access journals, which means that all articles are available on the internet to all users immediately upon publication. Non-commercial use and distribution in any medium is permitted, provided the author and the journal are properly credited.
Benefits of open access for authors, include:
- Free access for all users worldwide
- Authors retain copyright to their work
- Increased visibility and readership
- Rapid publication
- No spatial constraints
CONFLICT-OF-INTEREST STATEMENT FOR PUBLICATIONS
Send the form electronically to all contributing authors.
Each author must complete their own form on the screen.
In order for the Editors to make the best decision on how to handle a manuscript, it is important that any conflicts of interest that the authors or reviewers of a paper may have are disclosed on submission.
A conflict of interest exists when professional judgment concerning such primary interests as patients’ welfare or validity of research may be influenced by possible financial gain or personal rivalry. It may arise for the authors of an article when they have a financial interest that may influence their interpretation of their results or those of others.
When completing the form below, authors should be aware that questions 1–4 relate to the present article, and that questions 5–7 relate to both the present article and to possible conflicts of interest that the author themselves may have, beyond the bounds of this study.
The Editors will not reject papers simply because of a conflict of interest but believe that any competing interests should be acknowledged and openly stated; therefore, a declaration of interest will be published alongside the final published article.
Manuscript title: _________________________________
Manuscript number (if known): _____________
Publication title: __________________________
1. Have you, in the past 5 years, accepted the following from an organization that may in any way gain or lose financially from the results of your study or the conclusions of your review, editorial, or letter? Please mark ‘yes’ or ‘no’.
Reimbursement for attending a symposium – Yes No
A fee for speaking – Yes No
A fee for organizing education – Yes No
Funds for research – Yes No
Funds for a member of staff – Yes No
Fees for consulting – Yes No
Gifts exceeding €60 per year – Yes No
2. Have you, in the past 5 years, been employed by an organization that may in any way gain or lose financially from the results of your study or the conclusions of your review, editorial, or letter? Please mark the ‘yes’ or ‘no’. If you answer yes, please give details in the appropriate section later in this form.
3. Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the results of your study or the conclusions of your review, editorial, or letter? Please mark ‘yes’ or ‘no’. If you answer yes, please give details in the appropriate section later in this form.
4. Have you acted as an expert witness on the subject of your study, review, editorial, or letter? Please mark ‘yes’ or ‘no’. If you answer yes, please give details in the appropriate section later in this form.
5. Do you have any competing financial interests? Please mark ‘yes’ or ‘no’. If you answer yes, please give details in the appropriate section later in this form.
6. Are you or have you ever been in any relationship with or in receipt of any benefit (financial or other) from the tobacco industry or corporate affiliates? Please mark ‘yes’ or ‘no’. If you answer yes, please give details in the appropriate section later in this form.
7. Do you or your spouse knowingly hold stocks or shares in companies in the tobacco industry or companies involved in the tobacco industry? Please mark ‘yes’ or ‘no’. If you answer yes, please give details in the appropriate section later in this form.
If you have answered ‘yes’ to any of the above questions, the European Journal of Management Issues considers that you or your institution may have a conflict of interest, which, in the spirit of openness, should be declared. Please draft and add to this form a statement detailing these interests. This statement will be published alongside your article in the event of acceptance. An example of such a statement is given below:
Conflict of interests: ________ has received an educational grant from ________ Pharmaceutical industries; has stocks in excess of £_____ in _________; and travel to the ________ congress was funded by _____________________.
Please add your statement here: _____________________________
If you did not answer "yes" to any of the questions above, we will publish "Competing interests: None declared."
The above questions are limited to financial interests; however, you might want to disclose another sort of conflict of interest that would embarrass you if it became generally known after publication. The following list gives some examples:
A close relationship with, or a strong antipathy to, a person whose interests may be affected by the publication of your paper.
An academic link or rivalry with somebody whose interests may be affected by the publication of your paper.
Membership of a political party or special interest group whose interests may be affected by the publication of your paper.
A deep personal or religious conviction that may have affected what you wrote and that readers should be aware of when reading your paper.
If you want to declare such a competing interest then please add it to your statement above.
INFORMED CONSENT, PRIVACY, AND CONFIDENTIALITY STATEMENT
Patients and Study Participants: Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Patient consent should be written and archived with the journal, the authors, or both, as dictated by local regulations or laws. The Journal requires that all authors obtain written patient consent and that this be archived by the author and available for inspection for a period of at least three years. A written statement should be included in the manuscript that attests that the authors have obtained and archived written patient consent. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance, and editors should so note, that such alterations do not distort scientific meaning.
Manuscripts that include human subjects must include a statement that written informed consent was obtained. If materials or records derived from humans are included, the statement that approval from an Institutional Review Board (IRB) or Ethics Committee was obtained prior to initiation of the study, if it is required by the institution. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
The use of laboratory animals must follow the standards established by the NIH Office of Animal Care and Use (OACU ARAC guidelines) and the Institute for Laboratory Animal Research as published in the Guide for the Care and Use of Laboratory Animals (1996).
Manuscripts will be reviewed with due respect for authors’ and reviewers’ confidentiality. Our editors have been instructed to not disclose information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or ultimate fate) to anyone other than the authors and reviewers. Manuscripts sent for review are privileged communications. Therefore, reviewers and members of the editorial staff must respect the authors’ rights by not publicly discussing the authors’ work or appropriating their ideas before the manuscript is published. Reviewers may not make copies of the manuscript for their files and will not share it with others, except with the editor’s permission. Reviewers should return or destroy copies of manuscripts after submitting reviews.
PUBLICATION ETHICS AND PUBLICATION MALPRACTICE STATEMENT
European Journal of Management Issues follows the Publication Ethics and Publication Malpractice based on COPE's Best Practice Guidelines for Journal Editors to ensure ethics and quality in publication.
Oles Honchar Dnipro National University (DNU) as a publisher of European Journal of Management Issues takes its duties to guarantee a serious approach to all stages of publishing and recognizes its responsibilities. Advertising, reprint, and/or any commercial revenue have no influence on editorial decisions.
Compliance with standards of ethical behavior is therefore expected of all parties involved in the publishing process: Authors, Editors, Reviewers, and the Publisher.
Duties of the Editor and the Editorial Board
The Editor makes a decision on the publication of the submitted papers. It is guided by the journal’s policy and is based absolutely on the academic value and the conclusion of the reviewers. The Editor clings to the contemporary regulations regarding defamation, copyright violation, and plagiarism. He is entitled to carry out decision-making in consultation with reviewers or members of the editorial board.
An editor must not use unpublished information in the editor’s own research without the express written consent of the author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning the submitted manuscript or published paper.
An editor evaluates manuscripts without regard to previous merits, race, ethnic origin, gender, religion, citizenship, sexual orientation, or political philosophy of the authors.
The Editor and Editorial Board do not disclose any information about a submitted manuscript (author(s), topic, text, etc.) to anyone other than the corresponding author, (potential) reviewers, and the publisher, as appropriate.
Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in any research of the editor, reviewers, or any other informed person without the written consent of the authors. Privileged information or arguments obtained through peer review must be kept confidential and not used for personal or third-party advantage. Editor and any member of the editorial board should release themselves from the duties of considering manuscripts in case of any conflicts of interest resulting from collaborative, competitive, or other relationships or connections with any of the authors, companies/institutions having relevance to the manuscripts. The editor should require all contributors to disclose relevant competing interests. In case of revealing the competing interests after publication, the corrections should be published. A retraction or expression of concern may be published if needed.
Ensuring integrity: involvement and cooperation.
European Journal of Management Issues will respond to all claims or doubt of research or publication misconduct raised by readers, reviewers, or others. If concerns about the conduct or validity of academic work are raised, the Editorial Board with the involvement of relevant experts, as appropriate, will assess cases of a possible plagiarism or duplicate/redundant publication. The editor will also ask the author(s) about responding to the affairs. European Journal of Management Issues will take this to the institutional level: the journal may request an investigation by the institution or other appropriate bodies if that response is unsatisfactory.
In cases when concerns are very serious and the published work is likely to influence the scientific knowledge or practical applications, European Journal of Management Issues may consider informing readers about these concerns, by issuing an “expression of concern”, and then publish explanations of the findings of the investigation. Otherwise, European Journal of Management Issues may decide to retract a paper if the Editorial Board is persuaded that severe misconduct has happened. Retracted papers will be retained online, and conspicuously marked as a retraction for the readers’ benefit.
Duties of the Reviewers
Contribution to Editorial Decisions
Peer review is an obligatory step in making editorial decisions and, if necessary, in improving the paper through editorial communications with the author.
The reviewer asked for peer review, who feels the shortage of qualification in the research reported in a manuscript or knows about the lack of time that makes his/her review impossible at the appointed time should notify the editor and relieve himself from the review process.
Any manuscripts and supplementary materials received for review must be processed as confidential documents. They must not be shown to or discussed with third parties except as authorized by the editor.
Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is unsuitable. Referees should express their views clearly with supporting arguments.
Acknowledgment of Sources
Reviewers should indicate relevant published papers that have not been discussed/cited by the author(s). Any assertion that an observation, conclusion, or suggestion had been previously reported should be supported by the relevant citation. A reviewer should also inform about any important similarity or overlap between the manuscript under consideration and any other published paper.
Disclosure and Conflict of Interest
Privileged information or arguments obtained through peer review must be kept confidential and not used for personal or third-party advantage. Reviewers should release themselves from the duties of manuscripts consideration in case of any conflicts of interest resulting from collaborative, competitive, or other relationships or connections with any of the author(s), companies/institutions having relevance to the manuscripts.
Editors will take the reviewer’s misconduct seriously and investigate any evidence of confidentiality breach, non-declaration of conflicts of interest (both financial and non-financial), inappropriate use of confidential material, or delay of peer review for competitive advantage. Allegations of severe reviewer misconduct (e.g. plagiarism) will be taken to the institutional level.
Duties of Authors
Authors reporting results of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.
Data Access and Retention
Authors could be asked to provide the raw data of their study in connection with a paper for editorial review, and should be prepared to provide public access to such data if practicable. Authors should in any event be prepared to retain such data for a reasonable time after publication. The confidentiality of the participants can be protected and legal rights concerning proprietary data do not preclude their release.
Originality and Plagiarism
Authors should ensure that the submitted manuscript:
- describes entirely original work;
- is not plagiarized;
- has not been published elsewhere in any language;
- indicates appropriate citation or quotation, if the authors have used the work and/or words of others.
Applicable copyright laws and conventions should be followed. Copyright material (e.g. tables, figures or extensive quotations) should be reproduced only with appropriate permission and acknowledgment.
Multiple, Redundant, or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently creates unethical publishing conduct and is unacceptable.
Acknowledgment of Sources
Authors will submit only entirely original works, and proper acknowledgment of other works must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.
Authorship of a manuscript
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be named in an Acknowledgement section.
The corresponding author should ensure that all contributing co-authors (according to the above definition) and no uninvolved co-authors are included in the author list of the manuscript and that all co-authors have approved the final version of the paper and have agreed to its submission for publication.
If the work involves chemicals, procedures, or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
Reporting of research involving humans or animals
Bioethics principles should be adhered to while carrying out the research. Appropriate approval, licensing, or registration should be obtained before the research begins and details should be provided (e.g. Institutional Review Board, Research Ethics Committee approval, or national licensing authorities for the use of animals).
If requested by editors, authors should supply evidence that the reported research received the appropriate approval and was carried out ethically (e.g. copies of approvals, licenses, participant consent forms).
Researchers should not generally publish or disclose identifiable individual data collected in the course of research without specific consent from the individual (or their official representative).
Authors should submit research protocols to the editors if requested (e.g. for clinical trials) so that reviewers and editors can compare the research report to the protocol to check that it was carried out properly and that no relevant details have been missed.
Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or other substantive conflicts of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to notify the journal editor or publisher promptly and cooperate with the editor to retract or correct the paper.
Neither the editors nor the Editorial Board is responsible for authors’ expressed opinions, views, and the contents of the published manuscripts in the journal. The originality, proofreading of manuscripts, and errors are the sole responsibility of the individual authors.
All manuscripts submitted for review and publication in European Journal of Management Issues go under double-blind reviews for authenticity, ethical issues, and useful contributions. Decisions of the reviewers are the only tool for publication in the journal and will be final.
Committee on Publication Ethics (COPE). (2011, March 7). Code of Conduct and Best-Practice Guidelines for Journal Editors. Retrieved from http://publicationethics.org/files/Code_of_conduct_for_journal_editors_Mar11.pdf